Jessica Bracken, MD
Obstetrics & Gynecology · Elkhorn, NENPI 1528220209
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,405 of the $7,846 with a category attached, or 81.6%. 30 manufacturers reported payments, led by Axonics, Inc. at 32.6% of the total. Reporting peaked in 2021 at $2,423 and has fallen 63.3% since, to $890 in 2025. Among obstetrics & gynecology clinicians in NE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 217 payments — averaging $36.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axonics, Inc.$3K
- Caldera Medical, Inc$1K
- Sumitomo Pharma America, Inc.$703
- Astellas Pharma US Inc$589
- AbbVie$563
- Boston Scientific$388
- plus $2K from 24 others
What the payments were for
- Travel & lodging$1,20815%
- Food & beverage$6,40582%
- Education$1932%
- Gifts$391%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axonics, Inc. | 23 | $2,557 |
| Caldera Medical, Inc | 13 | $1,061 |
| Sumitomo Pharma America, Inc. | 29 | $703 |
| Astellas Pharma US Inc | 25 | $589 |
| AbbVie(2 entities) | 32 | $563 |
| Boston Scientific | 8 | $388 |
| Pfizer | 22 | $327 |
| Medtronic(2 entities) | 6 | $169 |
| Myovant Sciences Inc. | 8 | $159 |
| Merz North America, Inc. | 2 | $157 |
| Urovant Sciences Inc | 2 | $135 |
| 180 Medical, Inc. | 5 | $134 |
| Hologic Sales And Service, LLC | 2 | $128 |
| Vertex | 4 | $101 |
| Coloplast | 6 | $93 |
| Bayer | 4 | $87 |
| Mayne Pharma Commercial LLC | 7 | $84 |
| Baxter Healthcare | 2 | $79 |
| Exeltis, USA Inc. | 4 | $70 |
| C. R. Bard, Inc. & Subsidiaries | 2 | $62 |
| Laborie Medical Technologies Corp. | 2 | $47 |
| Gynesonics, Inc. | 1 | $22 |
| Abbott | 1 | $21 |
| Amgen | 1 | $21 |
| Exact Sciences | 1 | $18 |
| Northgate Technologies, Inc. | 1 | $17 |
| Coopersurgical, Inc. | 1 | $15 |
| Bausch Health US, LLC | 1 | $14 |
| Therapeuticsmd, Inc. | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Axonics r-SNM System$1,785
- Bulkamid$1,331
- Desara$872
- Axonics$544
- Advantage System$142
- XEOMIN$124
- ASCLERA$124
- MYFEMBREE$122
- GEMTESA$119
- ACESSA PROVU SYSTEM$111
How this compares
$7,846 in reported general payments places this provider in the 95th percentile of 242 obstetrics & gynecology providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 161 | $117,507 |
| MyrbetriqMirabegron | 180 | $109,071 |
| Methenamine Hippurate | 208 | $12,483 |
| BotoxOnabotulinumtoxina | 13 | $11,813 |
| Estradiol | 110 | $8,476 |
| Mirabegron ErMirabegron | 14 | $5,244 |
| Solifenacin Succinate | 86 | $2,815 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 114 | $1,667 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 12 | $986 |
| Clobetasol Propionate | 27 | $804 |
| GlydoLidocaine Hcl | 13 | $706 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 121 | $439 |
| Ciprofloxacin Hcl | 84 | $345 |
| Cephalexin | 53 | $207 |
| Oxybutynin Chloride ErOxybutynin Chloride | 12 | $144 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $703 | $117,507161 claims |
| Astellas Pharma US IncMyrbetriq | $589 | $109,071180 claims |
| AbbVieBotox | $563 | $11,81313 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 242 obstetrics & gynecology providers in Nebraska.
Other obstetrics & gynecology in Elkhorn
- Carolee JonesElkhorn$4K
- Judith ScottElkhorn$3K
- Allison PhillipsElkhorn$2K
- William WeidnerElkhorn$2K
- John CoteOmaha$236K
- Gregory HeidrickLincoln$80K
- Robin ClemmerOmaha$19K
- Angela GroneBeatrice$17K
- Chandra LjunggrenLincoln$13K
- Emily NeriLincoln$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.